Navigation Links
New research suggests that obesity and diabetes are a downside of human evolution
Date:2/24/2011

As if the recent prediction that half of all Americans will have diabetes or pre-diabetes by the year 2020 isn't alarming enough, a new genetic discovery published online in the FASEB Journal (http://www.fasebj.org) provides a disturbing explanation as to why: we took an evolutionary "wrong turn." In the research report, scientists show that human evolution leading to the loss of function in a gene called "CMAH" may make humans more prone to obesity and diabetes than other mammals.

"Diabetes is estimated to affect over 25 million individuals in the U.S., and 285 million people worldwide," said Jane J. Kim, M.D., a researcher involved in the work from the Department of Pediatrics at the University of California, San Diego in La Jolla, CA. "Our study for the first time links human-specific sialic acid changes to insulin and glucose metabolism and therefore opens up a new perspective in understanding the causes of diabetes."

In this study, which is the first to examine the effect of a human-specific CMAH genetic mutation in obesity-related metabolism and diabetes, Kim and colleagues show that the loss of CMAH's function contributes to the failure of the insulin-producing pancreatic beta cells in overweight humans, which is known to be a key factor in the development of type 2 diabetes. This gene encodes for an enzyme present in all mammalian species except for humans and adds a single oxygen atom to sialic acids, which are sugars that coat the cell surface.

To make their discovery, the researchers used two groups of mice. The first group had the same mutant CMAH gene found in humans. These mice demonstrated that the CMAH enzyme was inactive and could not produce a sialic acid type called NeuSGc at the cell surface. The second group had a normal CMAH gene. When exposed to a high fat diet, both sets of mice developed insulin resistance as a result of their obesity. Pancreatic beta cell failure, however, occurred only in the CMAH mutant mice that lacked NeuSGc, resulting in a decreased insulin production, which then further impaired blood glucose level control. This discovery may enhance scientific understanding of why humans may be particularly prone to develop type 2 diabetes. Results may also suggest that conventional animal models may not accurately mirror the human situation.

"The diabetes discovery is an important advance in its own right. It tells us a lot about what goes wrong in diabetes, and where to aim with new treatments," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal, "but its implications for human evolution are even greater. If this enzyme is unique to humans, it must also have given us a survival advantage over earlier species. Now the challenge is to find the function of CMAH in defending us against microbes or environmental stress or both. This evolutionary science explains how we can win some and lose some, to keep our species ahead of the extinction curve."


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. Researcher lists more than 4,000 components of blood chemistry
2. Cleveland Clinic researchers honored for contributions to science and technology
3. UT researchers crack code to harmful brown tides
4. Albert Einstein College of Medicine geneticist wins Sloan Research Fellowship
5. Nanowire research at Stevens makes cover of Applied Physics Letters
6. Iowa State, Ames Lab researchers describe the pump that bacteria use to resist drugs
7. Researchers achieve a full film frame of a family of proteins essential for cell function
8. Researchers find local wildlife protection safeguards entire range
9. Elsevier and the Arabidopsis Information Resource connect research articles
10. Stanford researchers develop new technology for cheaper, more efficient solar cells
11. Tip sheet: Caltech researchers presenting at AAAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2018)... ... December 18, 2018 , ... CP Merritt is a ... been competing for many years however in 2006, he had a medical setback that ... was determined that he suffered from cartilage degeneration in his right rear fetlock. ...
(Date:12/13/2018)... ... December 12, 2018 , ... Illumina, Kaiser Permanente, ResMed and Aetna were just ... Diego-based team-building and cooking events company has hosted an impressive guest list of Fortune ... , Each group who visits receives a completely customized experience, right down to ...
(Date:12/6/2018)... ... December 06, 2018 , ... Stewart has been ... contract services, throughout his career. During his recent five-year tenure with InSphero he ... established the commercial laboratory operations in Brunswick, Maine. Through these experiences, Stewart has ...
Breaking Biology News(10 mins):
(Date:1/4/2019)... RESEARCH TRIANGLE PARK, N.C. (PRWEB) , ... January ... ... sciences consulting organization, is pleased to welcome Ted Hoffman to the firm. Ted ... than 20 years of experience working in and providing consulting services to the ...
(Date:12/19/2018)... ... December 19, 2018 , ... R3 Stem ... Stem Cell Training Course in Las Vegas. Training includes facial rejuvenation, hair restoration ... in popularity nationwide for aesthetics, having the training from expert, Board Certified providers ...
(Date:12/14/2018)... ... December 14, 2018 , ... NOVA OCULUS ... given the green light to immediately begin a clinical patient trial in Edmonton ... devices bureau of Health Canada has granted what is called an Investigational Testing ...
(Date:12/10/2018)... ... December 10, 2018 , ... ... Development and Manufacturing Organization (CDMO) with sites in China and the United ... and aseptic fill finish solutions for monoclonal antibody (mAb) and antibody-drug conjugate ...
Breaking Biology Technology: